Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew T Roe

Showing results (11-20 of 467) with videos related to

Pageof 47
Sort By:
Nature Clinical Practice. Cardiovascular Medicine|July 29, 2006
ASSENT-4 PCI: should facilitated percutaneous coronary intervention be used in clinical practice?Kanwar P Singh, Matthew T Roe
The New England Journal of Medicine|January 11, 2013
Prasugrel versus clopidogrel for acute coronary syndromesMatthew T Roe, E Magnus Ohman,
The New England Journal of Medicine|December 19, 2019
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary DiseaseGuillaume Marquis-Gravel, Matthew T Roe
JACC. Cardiovascular Interventions|June 21, 2014
Uncovering the shroud on antiplatelet therapy for patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary interventionMatthew T Roe, Matthew W Sherwood
Journal of the American Heart Association|October 25, 2014
Soluble urokinase-type plasminogen activator receptor: a useful biomarker for coronary artery disease and clinical outcomes?Ralf E Harskamp, Matthew T Roe
Diabetes & Vascular Disease Research|November 25, 2005
Acute coronary syndromes and diabetes mellitusBenjamin H Trichon, Matthew T Roe
The Journal of Emergency Medicine|January 1, 2008
The role of fibrinolytics in the prehospital treatment of ST-elevation myocardial infarction (STEMI)Assaad J Sayah, Matthew T Roe
Lancet (London, England)|December 4, 2014
Time to treatment as a quality metric for acute STEMI careJacob A Doll, Matthew T Roe
Drugs & Aging|October 17, 2002
Pharmacological treatment of elderly patients with acute coronary syndromes without persistent ST segment elevationManesh R Patel, Matthew T Roe
American Heart Journal|May 17, 2005
Improvements in quality improvementMatthew T Roe, Eric D Peterson
Pageof 47

Showing results (11-20 of 467) with videos related to

Sort By:
Pageof 47
Nature Clinical Practice. Cardiovascular Medicine|July 29, 2006
ASSENT-4 PCI: should facilitated percutaneous coronary intervention be used in clinical practice?Kanwar P Singh, Matthew T Roe
The New England Journal of Medicine|January 11, 2013
Prasugrel versus clopidogrel for acute coronary syndromesMatthew T Roe, E Magnus Ohman,
The New England Journal of Medicine|December 19, 2019
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary DiseaseGuillaume Marquis-Gravel, Matthew T Roe
JACC. Cardiovascular Interventions|June 21, 2014
Uncovering the shroud on antiplatelet therapy for patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary interventionMatthew T Roe, Matthew W Sherwood
Journal of the American Heart Association|October 25, 2014
Soluble urokinase-type plasminogen activator receptor: a useful biomarker for coronary artery disease and clinical outcomes?Ralf E Harskamp, Matthew T Roe
Diabetes & Vascular Disease Research|November 25, 2005
Acute coronary syndromes and diabetes mellitusBenjamin H Trichon, Matthew T Roe
The Journal of Emergency Medicine|January 1, 2008
The role of fibrinolytics in the prehospital treatment of ST-elevation myocardial infarction (STEMI)Assaad J Sayah, Matthew T Roe
Lancet (London, England)|December 4, 2014
Time to treatment as a quality metric for acute STEMI careJacob A Doll, Matthew T Roe
Drugs & Aging|October 17, 2002
Pharmacological treatment of elderly patients with acute coronary syndromes without persistent ST segment elevationManesh R Patel, Matthew T Roe
American Heart Journal|May 17, 2005
Improvements in quality improvementMatthew T Roe, Eric D Peterson
Pageof 47